SNDX
Syndax Pharmaceuticals Inc.
Latest News for SNDX
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Genmab (GMAB – Research Report), Omnicell (OMCL – Re......
In a report released today, Jason Zemansky from Bank of America Securities maintained a Buy rating on Syndax Pharmaceuticals, with a price target o......
Barclays analyst Etzer Darout maintained a Buy rating on Syndax Pharmaceuticals today and set a price target of $35.00. According to TipRanks, Daro......
In a report released today, Etzer Darout from Barclays maintained a Buy rating on Syndax Pharmaceuticals, with a price target of $35.00. Darout cov......
In a report released today, from Mizuho Securities maintained a Buy rating on Syndax Pharmaceuticals, with a price target of $45.00. In a report re......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SNDX | $20.37 | -0.2% | 1.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Syndax Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW